Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.
about
Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.A virus-induced molecular mimicry model of multiple sclerosisMolecular mimicry as an inducing trigger for CNS autoimmune demyelinating diseaseClass I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cellsThe thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipientsThymic selection generates a large T cell pool recognizing a self-peptide in humansT cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritisGene therapy for carcinoma of the breast: Genetic immunotherapyThe cancer stem cell: evidence for its origin as an injured autoreactive T cellA Deeper Look into Type 1 Diabetes - Imaging Immune Responses during Onset of DiseaseVirus infections in type 1 diabetesA novel technique for the in vivo imaging of autoimmune diabetes development in the pancreas by two-photon microscopyGenetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteinsT-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agentsImmunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?Cish actively silences TCR signaling in CD8+ T cells to maintain tumor toleranceComparison of osteogenic potentials of human rat BMP4 and BMP6 gene therapy using [E1-] and [E1-,E2b-] adenoviral vectors.ARIH2 is essential for embryogenesis, and its hematopoietic deficiency causes lethal activation of the immune systemOpinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetesA lung-specific neo-antigen elicits specific CD8+ T cell tolerance with preserved CD4+ T cell reactivity. Implications for immune-mediated lung disease.Antigen mimicry in autoimmune disease sharing of amino acid residues critical for pathogenic T cell activationDonor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejectionA study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell functionBlood glucose levels regulate pancreatic beta-cell proliferation during experimentally-induced and spontaneous autoimmune diabetes in mice.Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?Immunity and tolerance are related, and governed by antigen migration and localizationEosinophils in Autoimmune Diseases.Organ injury associated with extrathymic induction of immune tolerance in doubly transgenic mice.Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity.Bacterial and viral superantigens: roles in autoimmunity?Role of dendritic cells in the induction and maintenance of autoimmune diseases.Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice.Role of autoreactive CD8+ T cells in organ-specific autoimmune diseases: insight from transgenic mouse models.The central and multiple roles of B cells in lupus pathogenesis.Different modes of pathogenesis in T-cell-dependent autoimmunity: clues from two TCR transgenic systems.Autoaggression and tumor rejection: it takes more than self-specific T-cell activation.Transgenic expression of Hsc70 in pancreatic islets enhances autoimmune diabetes in response to beta cell damageIn vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen.The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo.
P2860
Q24537348-59260B69-274D-4010-83BA-80DAA7381974Q24569603-57C91ECF-7B00-4CE3-A757-21501FA55145Q24613288-67559125-E99F-4FD3-B22C-2385752C917EQ24653129-F8194144-EC45-4A7F-9868-9CC2E996CC2BQ24669714-3FB049BE-6D36-4889-AEBC-78553F8898DEQ24675080-32B9F543-5075-4E54-8E3C-007D8AF3F508Q24792514-3D310CBE-6078-4B87-94D9-08D10D1CD215Q24797848-22EEEB58-F652-4678-830A-898F7D25F0B1Q25256839-98728EE6-2E7A-48A9-AF30-A705BB1A151DQ26738317-E0B3B074-2A25-404F-A6DE-53F6AD071388Q27000117-3AB9F037-5BDE-4C2F-9B65-55C308489479Q27438101-38707FAB-EA34-42C5-B15F-89134F5CE76FQ27470000-5B8DC795-8BB2-4F8B-99B6-608158F599F4Q27485358-661214C6-29DE-4D92-86DC-3068141B3688Q28069584-4B64B147-9C5C-48F0-A42D-A8A412A35347Q28269352-446CA9FD-7358-4AA7-AED3-4FDDC8DFDEE3Q28566709-4A252D5B-66B9-4CD2-9451-9FDCE8742C98Q28593507-902BC3F3-AC0B-4BD0-8B93-584DAFC7CDD4Q29393228-B9CFF1DD-F763-4D94-9A18-774032A572D5Q30448835-AD412327-31C8-4149-A1EA-353303CD1CE8Q30449280-0D6CD1B6-12F4-4F63-BF98-97BA939D4781Q30964993-A8086C5C-FA1C-498E-9E46-75B2D67008E1Q33281005-E4C49856-5ACB-4FD1-A60C-6C3BE85EE113Q33418309-23D38005-0DFD-45C6-9799-B5A648F62370Q33536297-063DDCD2-3121-434D-852E-0EF9B56A1083Q33542774-C22A84F5-F293-475A-A9D5-51F76BABC86BQ33607031-2B780EE4-7C77-4772-944C-6FEE9BDF606BQ33610544-D753BF41-9F2D-433D-BDC4-3CA8703DFF2FQ33630981-CEA670F5-7EEC-4F49-A2D5-75EF1A25B55AQ33633502-8AF9933D-F93F-4788-B1AF-903FE8BE6F8BQ33713274-1FC35F98-2320-40A5-99C8-BD612DE33A24Q33713280-CCC7318B-EA16-4CA1-AEAD-329F08E7695BQ33713291-B8DB9C4E-FD8C-4107-A80A-C394F10A97B0Q33713303-8D8D32C2-F001-41B0-9AE8-8FD02B273721Q33713313-8F1D82D4-1D8F-4B34-A0C2-ED87B68894F6Q33713362-369B98D6-02B4-402D-ADD6-A0A4739253CFQ33737841-D0409F66-1AC3-4E6A-B3CE-23A003CA3727Q33756565-A776C9E1-E0B3-4D62-8447-AC20E0837669Q33756662-75FCBFEA-1370-490A-B53E-9099BD7860C3Q33778844-BEA1036C-E8C4-4AB8-A107-9D3427DC7808
P2860
Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Ablation of "tolerance" and in ...... viral antigen transgenic mice.
@en
Ablation of "tolerance" and in ...... viral antigen transgenic mice.
@nl
type
label
Ablation of "tolerance" and in ...... viral antigen transgenic mice.
@en
Ablation of "tolerance" and in ...... viral antigen transgenic mice.
@nl
prefLabel
Ablation of "tolerance" and in ...... viral antigen transgenic mice.
@en
Ablation of "tolerance" and in ...... viral antigen transgenic mice.
@nl
P2093
P1433
P1476
Ablation of "tolerance" and in ...... viral antigen transgenic mice.
@en
P2093
Hengartner H
Odermatt B
Zinkernagel RM
P304
P356
10.1016/0092-8674(91)90164-T
P407
P577
1991-04-01T00:00:00Z